Europe Molecular Diagnostics Services Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2023 –2030 |
 Tamanho do mercado (ano base ) | USD 32,964.59 Thousand |
 Tamanho do mercado ( Ano de previsão) | USD 57,370.93 Thousand |
 CAGR |
% |
| Principais participantes do mercado |
>Mercado europeu de serviços de diagnóstico molecular, por tipo de serviço (serviços de reparação de instrumentos, serviços de formação, serviços de conformidade, serviços de calibração , serviços de manutenção, serviços de automação escaláveis, serviços chave na mão, serviços de deslocalização de instrumentos, personalização de hardware, serviços de garantia de desempenho, serviços de design e desenvolvimento, fornecimento Soluções de cadeia, serviços de introdução de novos produtos, serviços de fabrico, serviços ambientais e regulamentares, certificação e auditoria de sistemas de gestão médica , serviços de investigação clínica, serviços de consultoria e outros serviços), tecnologia (PCR, PCR em tempo real, sequenciação de nova geração e outras tecnologias ), Utilizador final ( hospitais , centros de diagnóstico, instituições académicas e de investigação e outros) Tendências e previsões do sector para 2030 .
Análise e insights de mercado de serviços de diagnóstico molecular da Europa
A crescente procura por testes, terapias e diagnósticos mais rápidos está a ajudar a impulsionar o crescimento global do mercado. O crescente financiamento no setor do diagnóstico molecular está também a ser atribuído ao crescimento do mercado. Os principais players do mercado estão altamente focados em vários novos serviços de diagnóstico. Além disso, a crescente prevalência de doenças crónicas e infeciosas contribui também para o aumento da procura no mercado.
O mercado europeu de serviços de diagnóstico molecular está a crescer no ano previsto devido ao aumento dos participantes no mercado e à disponibilidade de vários serviços avançados de diagnóstico molecular no mercado. Juntamente com isto, o número de colaborações governamentais e privadas aumentou no mercado, o que está a impulsionar ainda mais o crescimento do mercado. No entanto, o elevado custo associado às configurações dos laboratórios de diagnóstico molecular e outras instrumentações pode dificultar o crescimento do mercado no período de previsão.
As iniciativas estratégicas dos principais intervenientes no mercado, o aumento das colaborações governamentais e privadas e o aumento das atividades de I&D estão a proporcionar oportunidades para o crescimento do mercado. No entanto, as regulamentações governamentais rigorosas e a falta de profissionais qualificados são os principais desafios para o crescimento do mercado.
O mercado europeu de serviços de diagnóstico molecular deverá atingir os 57.370,93 milhares de dólares até 2030, contra 32.964,59 mil dólares em 2022, crescendo a um CAGR de 7,4% no período de previsão de 2023 a 2030.
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2023 a 2030 |
|
Ano base |
2022 |
|
Ano histórico |
2021 (personalizável para 2020 - 2016) |
|
Unidades Quantitativas |
Receita em mil dólares |
|
Segmentos cobertos |
Por tipo de serviço (serviços de reparação de instrumentos, serviços de formação, serviços de conformidade, serviços de calibração, serviços de manutenção, serviços de automatização escaláveis, serviços prontos a utilizar, serviços de deslocalização de instrumentos, personalização de hardware, serviços de garantia de desempenho, serviços de design e desenvolvimento, soluções para a cadeia de abastecimento, introdução de novos produtos Serviços, Serviços de Fabrico, Serviços Ambientais e Regulamentares, Certificação e Auditoria de Sistemas de Gestão Médica, Serviços de Investigação Clínica, Serviços de Consultoria e Outros Serviços ), Tecnologia (PCR, PCR em Tempo Real, Sequenciação de Próxima Geração e Outras Tecnologias), Utilizador Final (Hospitais , Centros de Diagnóstico, Instituições Académicas e de Investigação e Outros). |
|
Países abrangidos |
Alemanha, França, Reino Unido, Itália, Espanha, Países Baixos, Rússia, Dinamarca, Suíça, Turquia, Áustria, Noruega, Hungria, Lituânia, Irlanda, Polónia e resto da Europa. |
|
Participantes do mercado abrangidos |
F. Hoffmann-La Roche Ltd, Danaher, BIOMERIEUX, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, Abbott, DiaSorin SpA e Hologic, Inc, entre outros. |
Definição de mercado
O diagnóstico molecular é conhecido como o processo de identificação de uma doença através do estudo de moléculas como proteínas, ADN e ARN num tecido ou fluido. Estes serviços de diagnóstico molecular são utilizados como estratégia para pesquisar, analisar e diagnosticar determinadas moléculas com o auxílio de tecnologias em laboratório. São especialmente utilizados para a medição de um biomarcador específico nos fluidos, deteção de genes bacterianos com base na reação em cadeia da polimerase (PCR) e respostas moleculares de qualquer infeção específica. Estes serviços são utilizados para fornecer testes e diagnósticos mais eficientes.
Os serviços de diagnóstico molecular permitem aos investigadores e técnicos produzir resultados de forma eficiente e eficaz em menos tempo, o que impulsiona o mercado de serviços de diagnóstico molecular da Ásia-Pacífico. Além disso, com potencial para a prática clínica, estes serviços são utilizados para dar um apoio adicional para aumentar a eficiência no diagnóstico molecular e a presença de grandes players do mercado também contribui para o crescimento do mercado.
Dinâmica do mercado de serviços de diagnóstico molecular da Europa
Motoristas
- Aumento da prevalência de doenças crónicas e infeciosas
As doenças crónicas e infecciosas são actualmente a principal causa de morte entre os adultos em quase todos os países. A prevalência de doenças crónicas e infecciosas está a aumentar, o que faz com que as pessoas estejam mais dependentes dos laboratórios de diagnóstico e dos centros de diagnóstico de doenças. A crescente prevalência aumentou a procura de serviços de diagnóstico molecular para fornecer diagnósticos, terapias e resultados de testes precisos em menos tempo. Os comportamentos prejudiciais à saúde – especialmente o consumo de tabaco, a falta de actividade física, os maus hábitos alimentares e o consumo excessivo de álcool são os principais contribuintes para o aumento da prevalência de doenças crónicas e infecciosas. Estas doenças podem ser diagnosticadas por diversas técnicas como o imunoensaio, técnicas moleculares, PCR e técnicas de manipulação genética, entre outras. Consequentemente, a procura por serviços de diagnóstico molecular está a aumentar para satisfazer a procura do paciente por diagnóstico e tratamento mais rápidos.
A ocorrência de doenças crónicas e infeciosas é elevada e o número de testes moleculares também aumentou para diagnóstico e tratamento, a procura de produtos e serviços acabará por aumentar. Consequentemente, a crescente prevalência de doenças crónicas e infeciosas está a impulsionar o crescimento do mercado em todo o mundo.
- Aumento da procura por testes, terapias e diagnósticos mais rápidos
A procura por terapias especializadas de alto custo é maior no panorama atual. A consciencialização entre os consumidores sobre diagnósticos mais rápidos está a aumentar e a adoção de software analisador para diagnóstico molecular está a aumentar a um ritmo cada vez maior. O diagnóstico molecular produz resultados precisos e eficazes e tem aplicações indispensáveis no diagnóstico de doenças. As pessoas estão a preferir medicamentos personalizados que dependem da identificação de informações genéticas, epigenómicas e clínicas do indivíduo.
Além disso, nos últimos anos, os doentes estão a mudar para cuidados e tratamentos personalizados e a procura por testes moleculares, terapias e diagnósticos mais rápidos está a aumentar, o que pode atuar como um fator impulsionador para o crescimento do mercado em todo o mundo.
- Crescente financiamento no segmento do diagnóstico molecular
As iniciativas, esquemas e atividades de financiamento governamentais para apoiar e promover a inovação e o desenvolvimento aumentaram, como resultado, o segmento de diagnóstico molecular está a crescer rapidamente. Este segmento é parte integrante do controlo de doenças, pelo que o financiamento está a aumentar e os cientistas estão mais concentrados no desenvolvimento de novas ideias para o controlo de doenças e uma sobrevivência saudável. Mais uma vez, as doenças crónicas como o cancro tornaram-se dominantes em todo o mundo e a procura de tratamento especializado e de diagnóstico mais rápido está a aumentar.
À medida que o financiamento governamental e público aumenta para apoiar o segmento de diagnóstico molecular para melhores inovações e alternativas para um diagnóstico mais rápido, o mercado está a impulsionar ainda mais. Considerando os casos acima, pode-se prever que o crescente financiamento no segmento do diagnóstico molecular irá impulsionar o mercado num futuro próximo.
Oportunidade
-
Aumentar as atividades de investigação e desenvolvimento
As crescentes atividades de I&D oferecem opções alternativas para receber serviços de diagnóstico molecular a nível mundial, melhorando o acesso e reduzindo os custos associados aos serviços de diagnóstico. No entanto, todo o potencial do diagnóstico molecular não foi realizado com uma absorção lenta e fragmentada.
O aumento do programa de sensibilização, o aumento das iniciativas de sensibilização e o apoio governamental aumentaram a utilização de diagnósticos moleculares em diversas áreas. O aumento das atividades de I&D ajudará a aumentar o conhecimento para desenvolver produtos e processos novos ou melhorados. O design, o fabrico técnico e os testes de fase são frequentemente a parte mais importante das atividades de I&D que proporcionam a melhoria nos serviços.
Uma vez que os participantes do mercado estão constantemente envolvidos em atividades de I&D, é provável que mais serviços de diagnóstico molecular estejam envolvidos no mercado. Isto aumentaria a procura de serviços de diagnóstico molecular por parte de vários utilizadores finais, tais como hospitais, clínicas e centros de diagnóstico.
Restrição/Desafio
- Elevado custo associado a configurações de laboratórios de diagnóstico molecular e outras instrumentações
O laboratório de diagnóstico molecular é composto por diversas técnicas, como a hibridização in situ por fluorescência (FISH), o diagnóstico molecular baseado na reação em cadeia da polimerase (PCR), o perfil cromossómico interfásico, a impressão digital de ADN, entre outras. Existem vários serviços associados a um laboratório de diagnóstico molecular como o serviço de instalação, serviço de validação, serviço de retificação, serviços de automação, entre outros. Assim, os custos gerais de configuração e instrumentação do laboratório são muito elevados, o que se torna bastante difícil de estabelecer sem financiamento e investimentos governamentais e privados e isto pode restringir o crescimento do mercado.
Impacto pós-COVID-19 no mercado europeu de serviços de diagnóstico molecular
O pós-COVID-19 afetou positivamente o mercado. Um grande número da população foi afetado por esta pandemia e o número de testes de diagnóstico aumentou em todo o mundo. Principalmente, o diagnóstico de COVID-19 baseado em PCR aumentou. Assim, o COVID-19 afetou positivamente o mercado.
Desenvolvimento recente
- Em outubro de 2022, a F. Hoffmann-La Roche Ltd apresentou o seu portefólio de próxima geração de teste rápido de antigénio SARS-CoV-2 (“2.0”) sob a marca CE para autoteste e utilização profissional. Isto ajudou a empresa a prestar melhores serviços aos consumidores através destas inovações na organização.
Âmbito do mercado de serviços de diagnóstico molecular da Europa
O mercado europeu de serviços de diagnóstico molecular está segmentado em três segmentos notáveis com base no tipo de serviço, tecnologia e utilizador final. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e a fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para tomar decisões estratégicas para identificar as principais aplicações do mercado.
Por tipo de serviço
- Serviços de reparação de instrumentos
- Serviços de formação
- Serviços de manutenção
- Serviços de calibração
- Serviços de conformidade
- Serviços chave na mão
- Serviços de automação escaláveis
- Personalização de Hardware
- Serviços de realocação de instrumentos
- Serviços de garantia de desempenho
- Serviços de design e desenvolvimento
- Soluções para a cadeia de abastecimento
- Serviços de introdução de novos produtos
- Serviços de Manufatura
- Serviços Ambientais e Regulamentares
- Certificação e Auditoria de Sistemas de Gestão Médica
- Serviços de investigação clínica
- Serviços Consultivos
- Outros serviços
Com base no tipo de serviço, o mercado está segmentado em serviços de reparação de instrumentos, serviços de formação, serviços de manutenção, serviços de calibração, serviços de conformidade, serviços chave na mão, serviços de automatização escaláveis, personalização de hardware, serviços de realocação de instrumentos, serviços de garantia de desempenho, serviços de design e desenvolvimento, fornecimento de soluções de cadeia, serviços de introdução de novos produtos, serviços de fabrico, serviços ambientais e regulamentares, certificação e auditoria de sistemas de gestão médica, serviços de investigação clínica, serviços de consultoria e outros serviços.
Por tecnologia
- PCR
- PCR em tempo real
- Sequenciamento de nova geração
- Outras tecnologias
Com base na tecnologia, o mercado está segmentado em PCR, PCR em tempo real, sequenciação de nova geração, entre outras tecnologias.
Por utilizador final
- Hospitais
- Centros de diagnóstico
- Institutos Académicos e de Investigação
- Outros
Com base no utilizador final, o mercado está segmentado em hospitais, centros de diagnóstico, institutos académicos e de investigação, entre outros.
Análise/perspetivas regionais do mercado de serviços de diagnóstico molecular da Europa
O mercado europeu de serviços de diagnóstico molecular é analisado e são fornecidos insights e tendências do tamanho do mercado por país, tipo de serviço, tecnologia e utilizador final.
Os países abrangidos neste relatório são a Alemanha, França, Reino Unido, Itália, Espanha, Países Baixos, Rússia, Dinamarca, Suíça, Turquia, Áustria, Noruega, Hungria, Lituânia, Irlanda, Polónia e resto da Europa.
A Alemanha domina o mercado europeu de serviços de diagnóstico molecular em termos de quota de mercado e receitas de mercado e continuará a florescer o seu domínio durante o período de previsão.
Isto deve-se à implementação de programas de sensibilização entre as pessoas e o aumento do avanço tecnológico melhora ainda mais este crescimento do mercado.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações nas regulamentações do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados, como vendas de novos e de reposição, demografia do país, epidemiologia de doenças e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas europeias e os desafios enfrentados devido à elevada concorrência de marcas locais e nacionais, e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Cenário competitivo e análise da quota de mercado dos serviços de diagnóstico molecular da Europa
O panorama competitivo do mercado europeu de serviços de diagnóstico molecular fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, presença na Europa, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura e amplitude do produto e domínio de aplicação . Os dados acima fornecidos estão apenas relacionados com o foco das empresas no mercado.
Alguns dos principais players que operam no mercado europeu de serviços de diagnóstico molecular são a F. Hoffmann-La Roche Ltd, Danaher, BIOMERIEUX, QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc, Abbott, DiaSorin SpA e Hologic, Inc. .
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
5.1.2 INCREASING DEMAND FOR TESTING, THERAPIES, AND FASTER DIAGNOSTICS
5.1.3 GROWING FUNDINGS IN MOLECULAR DIAGNOSTICS SEGMENT
5.2 RESTRAINTS
5.2.1 HIGH-COST ASSOCIATED WITH MOLECULAR DIAGNOSTICS LABS SET-UPS AND OTHER INSTRUMENTATIONS
5.2.2 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY KEY PLAYERS
5.3.2 RISING GOVERNMENT AND PRIVATE COLLABORATIONS
5.3.3 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
5.4 CHALLENGES
5.4.1 STRINGENT REGULATIONS
5.4.2 LACK OF SKILLED PROFESSIONALS
6 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE
6.1 OVERVIEW
6.2 INSTRUMENT REPAIR SERVICES
6.2.1 ON-SITE REPAIR SERVICES
6.2.1 OFF-SITE REPAIR SERVICES
6.3 MAINTENANCE SERVICES
6.4 TRAINING SERVICES
6.4.1 PCR BASED MOLECULAR DIAGNOSTICS
6.4.2 IMMUNOHISTOCHEMISTRY (IHC)
6.4.3 VIRAL LOAD TESTING
6.4.4 INTERPHASE CHROMOSOME PROFILING (ICP)
6.4.5 APPLICATION TRAINING SERVICES
6.5 CALIBRATION SERVICES
6.6 COMPLIANCE SERVICES
6.6.1 IQ/OQ & PM/OQ SERVICES
6.6.2 INSTALLATION SERVICES
6.6.3 VALIDATION SERVICES
6.6.4 OTHER SERVICES
6.7 TURNKEY SERVICES
6.8 SCALABLE AUTOMATION SERVICES
6.8.1 AUTOMATION FOR HIGH-CONTENT SCREENING (HCS)
6.8.2 AUTOMATION FOR HIGH-THROUGHPUT PLATE-BASED ASSAYS
6.8.3 AUTOMATION FOR HIGH-THROUGHPUT CLONE SCREENING
6.9 HARDWARE CUSTOMIZATION
6.1 INSTRUMENT RELOCATION SERVICES
6.10.1 PLATE RECERTIFICATION
6.10.2 FACTORY-APPROVED PARTS
6.10.3 INSTRUMENT PERFORMANCE EVALUATION
6.10.4 OTHER SERVICES
6.11 PERFORMANCE ASSURANCE SERVICES
6.12 DESIGN AND DEVELOPMENT SERVICES
6.13 SUPPLY CHAIN SOLUTIONS
6.14 NEW PRODUCT INTRODUCTION SERVICES
6.15 MANUFACTURING SERVICES
6.16 ENVIRONMENTAL AND REGULATORY SERVICES
6.17 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
6.18 CLINICAL RESEARCH SERVICES
6.19 CONSULTATIVE SERVICES
6.2 OTHER SERVICES
7 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 REAL TIME PCR
7.2.1 INSTRUMENT REPAIR SERVICES
7.2.2 MAINTENANCE SERVICES
7.2.3 TRAINING SERVICES
7.2.4 CALIBRATION SERVICES
7.2.5 COMPLIANCE SERVICES
7.2.6 TURNKEY SERVICES
7.2.7 SCALABLE AUTOMATION SERVICES
7.2.8 HARDWARE CUSTOMIZATION
7.2.9 INSTRUMENT RELOCATION SERVICES
7.2.10 PERFORMANCE ASSURANCE SERVICES
7.2.11 DESIGN AND DEVELOPMENT SERVICES
7.2.12 SUPPLY CHAIN SOLUTIONS
7.2.13 NEW PRODUCT INTRODUCTION SERVICES
7.2.14 MANUFACTURING SERVICES
7.2.15 ENVIRONMENTAL & REGULATION SERVICES
7.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.2.17 CLINICAL RESEARCH SERVICES
7.2.18 CONSULTATIVE SERVICES
7.2.19 OTHER SERVICES
7.3 PCR
7.3.1 INSTRUMENT REPAIR SERVICES
7.3.2 MAINTENANCE SERVICES
7.3.3 TRAINING SERVICES
7.3.4 CALIBRATION SERVICES
7.3.5 COMPLIANCE SERVICES
7.3.6 TURNKEY SERVICES
7.3.7 SCALABLE AUTOMATION SERVICES
7.3.8 HARDWARE CUSTOMIZATION
7.3.9 INSTRUMENT RELOCATION SERVICES
7.3.10 PERFORMANCE ASSURANCE SERVICES
7.3.11 DESIGN AND DEVELOPMENT SERVICES
7.3.12 SUPPLY CHAIN SOLUTIONS
7.3.13 NEW PRODUCT INTRODUCTION SERVICES
7.3.14 MANUFACTURING SERVICES
7.3.15 ENVIRONMENTAL AND REGULATION SERVICES
7.3.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.3.17 CLINICAL RESEARCH SERVICES
7.3.18 CONSULTATIVE SERVICES
7.3.19 OTHER SERVICES
7.4 NEXT GENERATION SEQUENCING
7.4.1 INSTRUMENT REPAIR SERVICES
7.4.2 MAINTENANCE SERVICES
7.4.3 TRAINING SERVICES
7.4.4 CALIBRATION SERVICES
7.4.5 COMPLIANCE SERVICES
7.4.6 TURNKEY SERVICES
7.4.7 SCALABLE AUTOMATION SERVICES
7.4.8 HARDWARE CUSTOMIZATION
7.4.9 INSTRUMENT RELOCATION SERVICES
7.4.10 PERFORMANCE ASSURANCE SERVICES
7.4.11 DESIGN AND DEVELOPMENT SERVICES
7.4.12 SUPPLY CHAIN SOLUTIONS
7.4.13 NEW PRODUCT INTRODUCTION SERVICES
7.4.14 MANUFACTURING SERVICES
7.4.15 ENVIRONMENTAL AND REGULATION SERVICES
7.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
7.4.17 CLINICAL RESEARCH SERVICES
7.4.18 CONSULTATIVE SERVICES
7.4.19 OTHER SERVICES
7.5 OTHER TECHNOLOGIES
8 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.2.1 INSTRUMENT REPAIR SERVICES
8.2.2 MAINTENANCE SERVICES
8.2.3 TRAINING SERVICES
8.2.4 CALIBRATION SERVICES
8.2.5 COMPLIANCE SERVICES
8.2.6 TURNKEY SERVICES
8.2.7 SCALABLE AUTOMATION SERVICES
8.2.8 HARDWARE CUSTOMIZATION
8.2.9 INSTRUMENT RELOCATION SERVICES
8.2.10 PERFORMANCE ASSURANCE SERVICES
8.2.11 DESIGN AND DEVELOPMENT SERVICES
8.2.12 SUPPLY CHAIN SOLUTIONS
8.2.13 NEW PRODUCT INTRODUCTION SERVICES
8.2.14 MANUFACTURING SERVICES
8.2.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION AND AUDITING
8.2.17 CLINICAL RESEARCH SERVICES
8.2.18 CONSULTATIVE SERVICES
8.2.19 OTHER SERVICES
8.3 DIAGNOSTIC CENTERS
8.3.1 CLINICAL LABORATORIES
8.3.1.1 INSTRUMENT REPAIR SERVICES
8.3.1.2 Maintenance services
8.3.1.3 Training SERVICES
8.3.1.4 CALIBRATION SERVICES
8.3.1.5 COMPLIANCE SERVICES
8.3.1.6 TURNKEY SERVICES
8.3.1.7 SCALABLE AUTOMATION SERVICES
8.3.1.8 HARDWARE CUSTOMIZATION
8.3.1.9 INSTRUMENT RELOCATION SERVICES
8.3.1.10 PERFORMANCE Assurance SERVICES
8.3.1.11 DESIGN and DEVELOPMENT SERVICES
8.3.1.12 SUPPLY CHAIN SOLUTIONS
8.3.1.13 NEW PRODUCT INTRODUCTION SERVICES
8.3.1.14 MANUFACTURING SERVICES
8.3.1.15 ENVIRONMENTAL and REGULATory SERVICES
8.3.1.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING
8.3.1.17 CLINICAL RESEARCH SERVICES
8.3.1.18 CONSULTATIVE SERVICES
8.3.1.19 Other SERVICES
8.3.2 AMBULATORY SURGICAL CENTERS
8.3.2.1 INSTRUMENT REPAIR SERVICES
8.3.2.2 MAINTENANCE SERVICES
8.3.2.3 TRAINING SERVICES
8.3.2.4 CALIBRATION SERVICES
8.3.2.5 COMPLIANCE SERVICES
8.3.2.6 TURNKEY SERVICES
8.3.2.7 SCALABLE AUTOMATION SERVICES
8.3.2.8 HARDWARE CUSTOMIZATION
8.3.2.9 INSTRUMENT RELOCATION SERVICES
8.3.2.10 PERFORMANCE Assurance SERVICES
8.3.2.11 DESIGN and DEVELOPMENT SERVICES
8.3.2.12 SUPPLY CHAIN SOLUTIONS
8.3.2.13 NEW PRODUCT INTRODUCTION SERVICES
8.3.2.14 MANUFACTURING SERVICES
8.3.2.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.3.2.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION and AUDITING
8.3.2.17 CLINICAL RESEARCH SERVICES
8.3.2.18 CONSULTATIVE SERVICES
8.3.2.19 OTHER SERVICES
8.4 ACADEMIC AND RESEARCH INSTITUTES
8.4.1 INSTRUMENT REPAIR SERVICES
8.4.2 MAINTENANCE SERVICES
8.4.3 TRAINING SERVICES
8.4.4 CALIBRATION SERVICES
8.4.5 COMPLIANCE SERVICES
8.4.6 TURNKEY SERVICES
8.4.7 SCALABLE AUTOMATION SERVICES
8.4.8 HARDWARE CUSTOMIZATION
8.4.9 INSTRUMENT RELOCATION SERVICES
8.4.10 PERFORMANCE ASSURANCE SERVICES
8.4.11 DESIGN AND DEVELOPMENT SERVICES
8.4.12 SUPPLY CHAIN SOLUTIONS
8.4.13 NEW PRODUCT INTRODUCTION SERVICES
8.4.14 MANUFACTURING SERVICES
8.4.15 ENVIRONMENTAL AND REGULATORY SERVICES
8.4.16 MEDICAL MANAGEMENT SYSTEMS CERTIFICATION & AUDITING
8.4.17 CLINICAL RESEARCH SERVICES
8.4.18 CONSULTATIVE SERVICES
8.4.19 OTHER SERVICES
8.5 OTHERS
9 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION
9.1 EUROPE
9.1.1 GERMANY
9.1.2 FRANCE
9.1.3 U.K.
9.1.4 ITALY
9.1.5 SPAIN
9.1.6 RUSSIA
9.1.7 NETHERLANDS
9.1.8 SWITZERLAND
9.1.9 SWEDEN
9.1.10 BELGIUM
9.1.11 NORWAY
9.1.12 POLAND
9.1.13 DENMARK
9.1.14 TURKEY
9.1.15 FINLAND
9.1.16 REST OF EUROPE
10 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 F.HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 SERVICE PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DANAHER
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 BIOMERIEUX
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 SERVICE PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 QIAGEN
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 SERVICE PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 THERMO FISHER SCIENTIFIC
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 SERVICE PORTFOLIO
12.5.5 RECENT DEVELOPMENT
12.6 ABBOTT
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUE ANALYSIS
12.6.3 SERVICE PORTFOLIO
12.6.4 RECENT DEVELOPMENT
12.7 BIO-RAD LABORATORIES, INC
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 SERVICE PORTFOLIO
12.7.4 RECENT DEVELOPMENTS
12.8 DIASORIN
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUE ANALYSIS
12.8.3 SERVICE PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 HOLOGIC, INC
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUE ANALYSIS
12.9.3 SERVICE PORTFOLIO
12.9.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
Lista de Tabela
TABLE 1 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 1 EUROPE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 2 EUROPE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 3 EUROPE MAINTENANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 EUROPE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 5 EUROPE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 6 EUROPE CALIBRATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 EUROPE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 EUROPE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 9 EUROPE TURNKEY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 EUROPE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 EUROPE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 12 EUROPE HARDWARE CUSTOMIZATION IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 13 EUROPE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 EUROPE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 EUROPE PERFORMANCE ASSURANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 16 EUROPE DESIGN AND DEVELOPMENT SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 EUROPE SUPPLY CHAIN SOLUTIONS SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 18 EUROPE NEW PRODUCT INTRODUCTION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 EUROPE MANUFACTURING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 EUROPE ENVIRONMENTAL AND REGULATORY SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 EUROPE MEDICAL MANAGEMENT SYSTEMS AND AUDITING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 EUROPE CLINICAL RESEARCH SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 23 EUROPE CONSULTATIVE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 EUROPE OTHER SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 26 EUROPE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 EUROPE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 28 EUROPE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 29 EUROPE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 30 EUROPE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 EUROPE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 32 EUROPE OTHER TECHNOLOGIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 34 EUROPE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 EUROPE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 36 EUROPE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 EUROPE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 38 EUROPE CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 39 EUROPE AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 40 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 41 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 42 EUROPE OTHERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 43 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 44 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 45 EUROPE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 46 EUROPE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 47 EUROPE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 48 EUROPE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 49 EUROPE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 50 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 51 EUROPE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 52 EUROPE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 53 EUROPE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 54 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 55 EUROPE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE 2021-2030 (USD THOUSAND)
TABLE 56 EUROPE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 57 EUROPE CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 58 EUROPE AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 59 EUROPE ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 60 GERMANY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 61 GERMANY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 62 GERMANY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 63 GERMANY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 GERMANY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 65 GERMANY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 66 GERMANY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 67 GERMANY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 68 GERMANY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 69 GERMANY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 70 GERMANY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 71 GERMANY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 72 GERMANY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 73 GERMANY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 74 GERMANY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 75 GERMANY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 76 FRANCE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 FRANCE INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 78 FRANCE TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 FRANCE COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 80 FRANCE SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 81 FRANCE INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 82 FRANCE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 83 FRANCE REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 84 FRANCE PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 85 FRANCE NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 86 FRANCE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 87 FRANCE HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 88 FRANCE DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 89 FRANCE CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 90 FRANCE AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 FRANCE ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 92 U.K. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 U.K. INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 94 U.K. TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 95 U.K. COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 96 U.K. SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 97 U.K. INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 98 U.K. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 99 U.K. REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 100 U.K. PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 101 U.K. NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 102 U.K. MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 103 U.K. HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 104 U.K. DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 105 U.K. CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 106 U.K. AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 U.K. ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 108 ITALY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 109 ITALY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 110 ITALY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 111 ITALY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 ITALY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 113 ITALY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 114 ITALY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 115 ITALY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 116 ITALY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 117 ITALY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 118 ITALY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 119 ITALY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 120 ITALY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 121 ITALY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 122 ITALY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 123 ITALY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 124 SPAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 125 SPAIN INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 126 SPAIN TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 127 SPAIN COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 SPAIN SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 129 SPAIN INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 130 SPAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 131 SPAIN REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 132 SPAIN PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 133 SPAIN NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 134 SPAIN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 135 SPAIN HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 136 SPAIN DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 137 SPAIN CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 138 SPAIN AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 139 SPAIN ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 RUSSIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 141 RUSSIA INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 142 RUSSIA TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 143 RUSSIA COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 144 RUSSIA SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 145 RUSSIA INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 146 RUSSIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 147 RUSSIA REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 148 RUSSIA PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 149 RUSSIA NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 150 RUSSIA MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 151 RUSSIA HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 152 RUSSIA DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 153 RUSSIA CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 154 RUSSIA AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 155 RUSSIA ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 NETHERLANDS MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 157 NETHERLANDS INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 158 NETHERLANDS TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 159 NETHERLANDS COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 160 NETHERLANDS SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 161 NETHERLANDS INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 162 NETHERLANDS MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 163 NETHERLANDS REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 164 NETHERLANDS PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 165 NETHERLANDS NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 166 NETHERLANDS MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 167 NETHERLANDS HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 168 NETHERLANDS DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 NETHERLANDS CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 170 NETHERLANDS AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 171 NETHERLANDS ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 SWITZERLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 173 SWITZERLAND INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 174 SWITZERLAND TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 175 SWITZERLAND COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 176 SWITZERLAND SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 177 SWITZERLAND INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 178 SWITZERLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 179 SWITZERLAND REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 180 SWITZERLAND PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 181 SWITZERLAND NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 182 SWITZERLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 SWITZERLAND HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 184 SWITZERLAND DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 185 SWITZERLAND CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 SWITZERLAND AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 187 SWITZERLAND ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 188 SWEDEN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 189 SWEDEN INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 190 SWEDEN TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 191 SWEDEN COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 192 SWEDEN SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 193 SWEDEN INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 194 SWEDEN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 195 SWEDEN REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 196 SWEDEN PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 197 SWEDEN NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 198 SWEDEN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 199 SWEDEN HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 200 SWEDEN DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 201 SWEDEN CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 202 SWEDEN AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 203 SWEDEN ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 204 BELGIUM MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 205 BELGIUM INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 206 BELGIUM TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 207 BELGIUM COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 208 BELGIUM SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 209 BELGIUM INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 210 BELGIUM MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 211 BELGIUM REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 212 BELGIUM PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 213 BELGIUM NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 214 BELGIUM MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 215 BELGIUM HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 216 BELGIUM DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 217 BELGIUM CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 218 BELGIUM AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 219 BELGIUM ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 220 NORWAY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 221 NORWAY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 222 NORWAY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 223 NORWAY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 224 NORWAY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 225 NORWAY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 226 NORWAY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 227 NORWAY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 228 NORWAY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 229 NORWAY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 230 NORWAY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 231 NORWAY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 232 NORWAY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 233 NORWAY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 234 NORWAY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 235 NORWAY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 236 POLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 237 POLAND INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 238 POLAND TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 239 POLAND COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 240 POLAND SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 241 POLAND INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 242 POLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 243 POLAND REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 244 POLAND PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 245 POLAND NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 246 POLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 247 POLAND HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 248 POLAND DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 249 POLAND CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 250 POLAND AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 251 POLAND ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 252 DENMARK MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 253 DENMARK INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 254 DENMARK TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 255 DENMARK COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 256 DENMARK SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 257 DENMARK INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 258 DENMARK MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 259 DENMARK REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 260 DENMARK PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 261 DENMARK NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 262 DENMARK MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 263 DENMARK HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 264 DENMARK DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 265 DENMARK CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 266 DENMARK AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 267 DENMARK ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 268 TURKEY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 269 TURKEY INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 270 TURKEY TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 271 TURKEY COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 272 TURKEY SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 273 TURKEY INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 274 TURKEY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 275 TURKEY REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 276 TURKEY PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 277 TURKEY NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 278 TURKEY MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 279 TURKEY HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 280 TURKEY DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 281 TURKEY CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 282 TURKEY AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 283 TURKEY ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 284 FINLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 285 FINLAND INSTRUMENT REPAIR SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 286 FINLAND TRAINING SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 287 FINLAND COMPLIANCE SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 288 FINLAND SCALABLE AUTOMATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 289 FINLAND INSTRUMENT RELOCATION SERVICES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 290 FINLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2021-2030 (USD THOUSAND)
TABLE 291 FINLAND REAL TIME PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 292 FINLAND PCR IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 293 FINLAND NEXT GENERATION SEQUENCING IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 294 FINLAND MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 295 FINLAND HOSPITALS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 296 FINLAND DIAGNOSTIC CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 297 FINLAND CLINICAL LABORATORIES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 298 FINLAND AMBULATORY SURGICAL CENTERS IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 299 FINLAND ACADEMIC & RESEARCH INSTITUTES IN MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
TABLE 300 REST OF EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET, BY SERVICE TYPE, 2021-2030 (USD THOUSAND)
Lista de Figura
FIGURE 1 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION
FIGURE 2 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 SERVICE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET
FIGURE 14 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2022
FIGURE 15 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, 2023-2030 (USD THOUSAND)
FIGURE 16 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY SERVICE TYPE, LIFELINE CURVE
FIGURE 18 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2022
FIGURE 19 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, 2023-2030 (USD THOUSAND)
FIGURE 20 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 21 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY TECHNOLOGY, LIFELINE CURVE
FIGURE 22 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2022
FIGURE 23 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 24 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 26 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: SNAPSHOT (2022)
FIGURE 27 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022)
FIGURE 28 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 29 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 30 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: BY SERVICE TYPE (2023-2030)
FIGURE 31 EUROPE MOLECULAR DIAGNOSTICS SERVICES MARKET: COMPANY SHARE 2022 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
